1. Home
  2. FPF vs VIR Comparison

FPF vs VIR Comparison

Compare FPF & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Trust Intermediate Duration Preferred & Income Fund of Beneficial Interest

FPF

First Trust Intermediate Duration Preferred & Income Fund of Beneficial Interest

HOLD

Current Price

$18.30

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$9.32

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FPF
VIR
Founded
2013
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.5B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
FPF
VIR
Price
$18.30
$9.32
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$19.63
AVG Volume (30 Days)
119.7K
4.2M
Earning Date
01-01-0001
05-06-2026
Dividend Yield
8.08%
N/A
EPS Growth
N/A
17.49
EPS
N/A
N/A
Revenue
N/A
$68,556,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1,049.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.60
$4.16
52 Week High
$19.75
$10.91

Technical Indicators

Market Signals
Indicator
FPF
VIR
Relative Strength Index (RSI) 36.70 55.65
Support Level N/A $8.67
Resistance Level $18.95 $10.29
Average True Range (ATR) 0.21 0.59
MACD -0.05 -0.08
Stochastic Oscillator 15.13 40.12

Price Performance

Historical Comparison
FPF
VIR

About FPF First Trust Intermediate Duration Preferred & Income Fund of Beneficial Interest

First Trust Inter Dur Pref& Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek a high level of current income. Further, it has a secondary objective of capital appreciation. The Fund invests in the traditional preferred securities, hybrid preferred securities, floating rate & fixed-to-floating rate preferred securities, debt securities, convertible securities, and contingent convertible securities issued by U.S. and non-U.S. companies. Its investment portfolio includes industries such as Banks, Insurance, Capital Markets, Electric Utilities, Oil, Gas & Consumable Fuels, Food Products, and others.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

Share on Social Networks: